Tianjin Tianyao Pharmaceuticals , Ltd. Profit Margin

The latest profit margin for 600488.SS is 1.84% as of September 2026. That compares with 0.57% in the prior-year period — up 224.4% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside Tianjin Tianyao Pharmaceuticals , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 600488.SS's profit margin moved from 0.57% to 1.84% — a 224.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tianjin Tianyao Pharmaceuticals , Ltd.'s valuation or profitability profile.

Against its sector companies, 600488.SS currently prints 1.84% for profit margin, while the sector average sits near 13.23%. That is roughly 86.1% below the sector mean. Large gaps often invite a closer look at Tianjin Tianyao Pharmaceuticals , Ltd.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Tianjin Tianyao Pharmaceuticals , Ltd. converts resources into returns. At 1.84%, 600488.SS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 0.57% in the prior-year period — up 224.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 600488.SS's profit margin (1.84%), review year-over-year change from 0.57%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.